PsyBio Therapeutics: Funding, Investors & Team (Sep 2026)
PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. Psychoactive medications treat the illness by rewiring the brain through contemplation and a change of perception in combination with psychotherapy vs. Standard of care (SSRI’s, SNRI’s, MAOI’s, NDRI’s, etc…) which just chemically treat symptoms. Working in partnership with Miami University utilizing a proprietary platform technology to biologically synthesize psilocybin and other targeted next-generation active compounds in Psilocybe Cubensis and other fungi and plants. TSXV: #PSYB OTCQB: #PSYBF
PsyBio Therapeutics has raised $740k across 1 funding round on record, the most recent an undisclosed round of $740k announced in Dec 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PsyBio Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
PsyBio Therapeutics Funding Rounds
PsyBio Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
PsyBio Therapeutics Funding Compared to Other Biotechnology Startups
PsyBio Therapeutics' latest round of $740k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PsyBio Therapeutics in Biotechnology and Coconut Creek
Companies Similar to PsyBio Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
PsyBio Therapeutics Funding FAQs
What does PsyBio Therapeutics do?
PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. Psychoactive medications treat the illness by rewiring the brain through contemplation and a change of perception in combination with psychotherapy vs. Standard of care (SSRI’s, SNRI’s, MAOI’s, NDRI’s, etc…) which just chemically treat symptoms. Working in partnership with Miami University utilizing a proprietary platform technology to biologically synthesize psilocybin and other targeted next-generation active compounds in Psilocybe Cubensis and other fungi and plants. TSXV: #PSYB OTCQB: #PSYBF
How much funding has PsyBio Therapeutics raised?
PsyBio Therapeutics has raised $740k across 1 round on record. The most recent is an undisclosed round of $740k announced in Dec 2022.
When did PsyBio Therapeutics last raise funding?
PsyBio Therapeutics' most recent funding round on record is an undisclosed round of $740k, announced in Dec 2022.
Who founded PsyBio Therapeutics?
FundedIQ lists Rob Nathan (Founder) at PsyBio Therapeutics.
Where is PsyBio Therapeutics headquartered?
PsyBio Therapeutics is based in Coconut Creek, Florida, United States.
How many employees does PsyBio Therapeutics have?
PsyBio Therapeutics is in the 1-10 employee band.
How does PsyBio Therapeutics' funding compare to other Biotechnology startups?
PsyBio Therapeutics' latest round of $740k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's PsyBio Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PsyBio Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.